×
About 39,923 results

ALLMedicine™ Addiction Center

Research & Reviews  12,147 results

TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating...
https://doi.org/10.1038/s41380-022-01448-3
Molecular Psychiatry; Liu J, Wu R et. al.

Jan 27th, 2022 - Relapse remains a major challenge to the treatment of cocaine addiction. Recent studies suggested that the trace amine-associated receptor 1 (TAAR1) could be a promising target to treat cocaine addiction and relapse; however, the underlying mechan...

Modernizing regulations for treating opioid use disorder during the COVID-19 pandemic.
https://doi.org/10.1097/01.JAA.0000805844.19200.b3
JAAPA : Official Journal of the American Academy of Physi... Iacono TM

Jan 26th, 2022 - The opioid epidemic has been the most significant public health crisis in the United States during the past 30 years. In 2021, it was second only to COVID-19. What happens when two epidemics collide and what should policy makers do about it? This ...

Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Di...
https://doi.org/10.1001/jamanetworkopen.2021.44955
JAMA Network Open; Hawk K, McCormack R et. al.

Jan 26th, 2022 - Emergency departments (EDs) are increasingly initiating treatment for patients with untreated opioid use disorder (OUD) and linking them to ongoing addiction care. To our knowledge, patient perspectives related to their ED visit have not been char...

see more →

Guidelines  15 results

Medication for Adolescents and Young Adults With Opioid Use Disorder.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902443
The Journal of Adolescent Health : Official Publication O...

Jan 25th, 2021 - Opioid-related morbidity and mortality have risen in many settings globally. It is critical that practitioners who work with adolescents and young adults (AYAs) provide timely, evidence-based treatment for opioid use disorder (OUD). Such treatment...

Executive Summary of the American Society of Addiction Medicine (ASAM) Clinical Practic...
https://doi.org/10.1097/ADM.0000000000000732
Journal of Addiction Medicine; Lindsay DL, Freedman K et. al.

Sep 11th, 2020 - : The American Society of Addiction Medicine (ASAM) Clinical Practice Guideline on Alcohol Withdrawal Management provides guidance on the identification and management of alcohol withdrawal in adults with varying degrees of syndrome severity. The ...

Executive Summary of the Focused Update of the ASAM National Practice Guideline for the...
https://doi.org/10.1097/ADM.0000000000000635
Journal of Addiction Medicine; Crotty K, Freedman KI et. al.

Mar 27th, 2020 - : A Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder is published in the current issue of the Journal of Addiction Medicine. The focused update included a search of Medline's PubMed database from Janu...

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of th...
https://doi.org/10.1016/j.ajog.2019.03.022
American Journal of Obstetrics and Gynecology; Ecker J, Abuhamad A et. al.

Apr 1st, 2019 - Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American So...

Academy of Nutrition and Dietetics: Revised 2018 Standards of Practice and Standards of...
https://doi.org/10.1016/j.jand.2018.07.013
Journal of the Academy of Nutrition and Dietetics; Anderson Girard T, Russell K et. al.

Sep 29th, 2018 - In 2016, there were 44.7 million adults affected by mental illness, and 20.1 million people aged 12 years or older affected by substance use disorder. More than 8.2 million Americans are afflicted with co-occurring disorders or dual diagnosis, suc...

see more →

Drugs  1,012 results see all →

Clinicaltrials.gov  479 results

Interest of Auriculotherapy in the Management of Chronic Insomnia
https://clinicaltrials.gov/ct2/show/NCT04471168

Jan 21st, 2022 - Chronic insomnia affects a significant proportion of the French population with an estimated prevalence between 15% and 20%. This disease is mainly managed by general practitioners for whom benzodiazepines and Z-drugs (zopiclone, zolpidem) represe...

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD
https://clinicaltrials.gov/ct2/show/NCT04316559

Jan 21st, 2022 - Background. Opioid-agonist medications (methadone and buprenorphine) are the most effective treatments available for opioid addiction. However, they are not effective in all cases, and with the vast number of people requiring treatment in the curr...

Effect of a Pre-operative Internet-based Educational Video on Post Operative Opioid Consumption.
https://clinicaltrials.gov/ct2/show/NCT05202080

Jan 21st, 2022 - One of the most challenging issues in modern medicine is the current opioid epidemic. Given the association between opioid use after surgery and the development of opioid addiction, an essential goal of the medical community should be to develop s...

fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating
https://clinicaltrials.gov/ct2/show/NCT05200182

Jan 20th, 2022 - Emotional overeating is characterized by an excessive food intake in the context of intense emotional situations, such as acute stress one. Emotional overeating, as a behavioral trait, can increase the risk of to develop eating disorders or eating...

Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain
https://clinicaltrials.gov/ct2/show/NCT05196386

Jan 19th, 2022 - Many treatments with WHO grade III opioids are being introduced in the rheumatology department for non-cancerous pain. The duration of this treatment prescribed at discharge is often uncontrolled and sometimes leads to significant addiction. The t...

see more →

News  2,288 results

Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
https://www.medscape.com/viewarticle/967259

Jan 26th, 2022 - NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States. The verdict, whi...

Ketamine an 'Intriguing New Therapy' for Alcoholism
https://www.medscape.com/viewarticle/967220

Jan 25th, 2022 - Three weekly infusions of the dissociative anesthetic ketamine coupled with mindfulness-based relapse prevention therapy may help adults with alcohol use disorder (AUD) maintain abstinence, new research suggests. Preliminary results from a phase 2...

SCOTUS Stays Out of Texas Abortion Fight; Hospital ED Attack; New Omicron Variant
https://www.medpagetoday.com/infectiousdisease/covid19/96784

Jan 21st, 2022 - Note that some links may require registration or subscription. The Supreme Court refused to speed up a legal challenge to the 6-week Texas abortion ban. (AP) Speaking of Texas, in some rural parts of the state "maternity deserts" mean women must t...

Antidepressant Transparency; Intranasal Carbetocin Not OK'd; 2021: Year of Anxiety
https://www.medpagetoday.com/psychiatry/generalpsychiatry/96750

Jan 19th, 2022 - While reporting bias persists, developers of new antidepressants have increasingly disclosed negative clinical trial outcomes. "Positive trials have always been reliably published, but negative trials, while common, have long been swept under the ...

Trial Will Test Synthetic Cannabinoid for Weight Loss in Obesity
https://www.medscape.com/viewarticle/966836

Jan 19th, 2022 - Researchers are about to enroll the first patient in a pilot study of potential weight loss with nabilone — a manufactured cannabinoid similar to the active component of the marijuana (cannabis) plant. Although cannabis is associated with the "mun...

see more →

Patient Education  28 results see all →